USD 7.41
(19.71%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -692.14 Million USD | 8.92% |
2022 | -275.85 Million USD | -53.98% |
2021 | -179.14 Million USD | 21.23% |
2020 | -227.43 Million USD | -140.15% |
2019 | -94.7 Million USD | -71.86% |
2018 | -55.1 Million USD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | -52.37 Million USD | 21.09% |
2024 Q3 | -47.37 Million USD | 9.56% |
2024 Q1 | -66.37 Million USD | -18.78% |
2023 Q3 | -143.36 Million USD | -51.69% |
2023 FY | -251.25 Million USD | 8.92% |
2023 Q1 | 263.29 Million USD | 506.05% |
2023 Q2 | -94.5 Million USD | -135.89% |
2023 Q4 | -55.88 Million USD | 61.02% |
2022 Q2 | -69.4 Million USD | 1.53% |
2022 Q1 | -70.48 Million USD | -48.62% |
2022 Q3 | -71.12 Million USD | -2.48% |
2022 Q4 | -64.84 Million USD | 8.83% |
2022 FY | -275.85 Million USD | -53.98% |
2021 Q2 | -37.53 Million USD | 3.11% |
2021 Q4 | -47.42 Million USD | 14.48% |
2021 Q3 | -55.45 Million USD | -47.73% |
2021 FY | -179.14 Million USD | 21.23% |
2021 Q1 | -38.73 Million USD | 21.84% |
2020 FY | -227.43 Million USD | -140.15% |
2020 Q4 | -49.56 Million USD | 22.91% |
2020 Q3 | -64.28 Million USD | 26.81% |
2020 Q2 | -87.83 Million USD | -241.08% |
2020 Q1 | -25.75 Million USD | -5.14% |
2019 FY | -94.7 Million USD | -71.86% |
2019 Q4 | -24.49 Million USD | 4.88% |
2019 Q3 | -25.74 Million USD | -20.53% |
2019 Q2 | -21.36 Million USD | 7.51% |
2019 Q1 | -23.09 Million USD | 0.0% |
2018 FY | -55.1 Million USD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Doximity, Inc. | 163.87 Million USD | 522.353% |
Evolent Health, Inc. | -71.21 Million USD | -871.961% |
MultiPlan Corporation | 173.4 Million USD | 499.151% |
Phreesia, Inc. | -131.77 Million USD | -425.254% |
Teladoc Health, Inc. | -248.55 Million USD | -178.469% |
Veeva Systems Inc. | 429.33 Million USD | 261.213% |